Deliver eConsent to sites and study participants around the globe with confidence
IQVIA Patient Engagement Suite products enhance participant experience, deliver better data quality and insights, and improve clinical trial outcomes.
IQVIA Complete Consent is the user-friendly, feature-rich electronic consent solution designed to support diverse protocols at a global scale.
It provides an easy, secure way to deliver highly engaging, regulatory compliant electronic consent for trials of all types so you can optimize enrollment and engagement, while realizing efficiencies to achieve better outcomes across the entire study lifecycle.
The IQVIA IRT Solution: Comprehensive randomization and trial supply management solution continues to be trusted by trial partners across study phase, complexity, and therapeutic area.
Built on a robust, scalable platform, our patient-centric approach to technology delivery provides exceptional value and peace of mind for sponsors and their patients in clinical trials.
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
Accelerate trial start up by up to 75% with the industry’s largest digital assessment library.
As trial sponsors face increasing pressure to deliver new treatments to market faster, connected digital medical devices play a more critical role. IQVIA Connected Devices accelerates trial outcomes by streamlining the selection and deployment of medical devices to collect and analyze data.
Combine IQVIA’s IRT and eCOA solutions together to improve study quality, accelerate decision making, and reduce site and sponsor burden. Plus you can add the IQVIA Complete Consent option to support patient enrollment and study efficiency.
Seamlessly integrate best of breed, modular, interoperable technologies proven to optimize efficiency and enhance trial outcomes.
Interactions between patient organizations and life sciences companies
Part 2: How eConsent delivers value for sponsors
Interoperable technology that improves data quality and usability while optimizing trial conduct
A tailored solution gave a global oncology program the head start it needed
Don’t let vague consent forms prevent you from (re)using valuable specimens
How to deliver highly engaging informed consent for better study outcomes
IQVIA's Patient Engagement Framework supports comprehensive and consistent assessment and planning for the inclusion of patient needs and preferences
Electronic consent products set the stage for a better trial experience for all stakeholders, but many sites and sponsors are wary of giving up their paper-based past.
Deliver eConsent to sites and study participants around the globe with confidence
Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
Improve study quality, accelerate decision making and reduce site and sponsor burden by harnessing the power of IQVIA’s integrated Interactive Response Technology (IRT) and electronic Clinical Outcome Assessment (eCOA) solution.
Discover intelligent insights from streamlined data and sophisticated analytics to transform trial workflows.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.